Christy J. Oliger

Insider Reports History

Identity Who this page is about. 1 identity field
Location
Newton, MA
SEC source record Original filing metadata and source links. 1 source field
Owner filing signature
/s/ Joseph R. Young, Attorney-in-Fact
Source evidence Original filing metadata and source links. 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Christy J. Oliger

Form 4 holding Director

Vera Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
2,987
Estimated value
$128,528
Report date
07 Jun 2024
Price
$43.03
Ownership
Direct
Form 4 holding Director

Replimune Group, Inc.

Security class
Stock Option (right to buy)
Shares / value
44,500
Estimated value
Report date
01 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

LAVA Therapeutics NV

Security class
Common Shares (Right to Buy)
Shares / value
33,390
Estimated value
Report date
13 Feb 2025
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Director

RayzeBio, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
26 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

REATA PHARMACEUTICALS INC

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
26 Sep 2023
Price
Ownership
Direct
Underlying class
Class A common stock
Underlying amount
Form 4 holding Director

Sierra Oncology, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Christy J. Oliger

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .